A filed proposal
Representative Tom Oliverson filed H.B. 1236 on November 18. The official history lists filing as its latest action. This is proposed legislation, with no enacted prohibition.1
The control test and proposed consequences
The bill would bar PBM control or common control of pharmacies licensed under Texas Chapter 560. Its test lists ownership, contracts, audit authority and other mechanisms for directing or influencing operations or professional practice.2
It provides license denial, nonrenewal or revocation for prohibited relationships, and civil penalties of up to $10,000 per violation per day. Conditional Board authorizations could temporarily preserve specified limited-distribution drug access or support a bona fide pharmacy sale.2
The proposed act takes effect September 1, 2027. Board rules and reviews are due December 1, 2027, with the operational prohibition and related enforcement applying January 1, 2028. These dates depend on enactment.2
Operational analysis
Chad’s analysis: pharmacy leaders should track the control definition and the implementing criteria the bill would require the Board to adopt before drawing conclusions about a particular agreement. The appearance of audit authority or contracting language does not establish that every PBM audit or network contract would violate the proposal. Ownership, management rights and practical influence would need to be assessed against the final text and any implementing rules. A bill at the filing stage supports monitoring and contract mapping, rather than assuming a required exit or divestiture.2